Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. IDT Australia Ltd.
WARNING LETTER
•IDT Australia Ltd.•December 8, 2017

IDT Australia Ltd. – FDA Warning Letter, Dec 8, 2017

Record Details

The FDA inspected IDT Australia Ltd. from December 4-8, 2017, identifying significant CGMP deviations for active pharmaceutical ingredients (API) and violations for finished pharmaceuticals (21 CFR parts 210 and 211), rendering drugs adulterated. Key violations include: failure to adequately investigate out-of-specification (OOS) results and implement corrective actions for API, and the quality unit's failure to ensure critical deviations were resolved, leading to release of microbiologically contaminated API. For finished drugs, the firm failed to establish adequate laboratory control mechanisms (21 CFR 211.160(b)), ensure complete laboratory records (21 CFR 211.194(a)) by not reporting non-conforming test results, and establish an adequate quality control unit (21 CFR 211.22(a)) with proper data review authority, leading to data integrity issues. The FDA deemed the firm's responses inadequate and strongly recommended retaining a qualified consultant for remediation. Required actions include a comprehensive investigation into data inaccuracies, a risk assessment, and a management strategy with detailed CAPA plans, root cause analysis, and interim/long-term measures. Failure to correct these issues may result in withholding new application approvals and refusal of product admission into the U.S. A response is required within 15 working days.

Company
IDT Australia Ltd.
Inspection date
December 8, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Francis Godwin (Director)
  • Karen D'Orazio (Investigator)
  • Kent Bui
View Company Profile

ID · eb5a0988-d6ee-4e47-a3eb-dfde73b1c43c

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.160(b)21 CFR 211.194(a)21 CFR 211.22(a)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)21 U.S.C. 356C(b)

Full citation text and observation details available on the Dashboard.

Other documents for IDT Australia Ltd.
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore IDT Australia Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.